News
Uncovering the Hidden Drivers Behind Rising Cancer Rates in Asian American Communities
Cancer has long been the leading cause of death for many Asian American communities, yet important differences in cancer risk across Asian ethnic groups are often overlooked. Researchers leading the Greater Bay Area Cancer Registry are working to better understand these disparities — including
Walk to End Bladder Cancer Raises $120K and Lights Up City Hall
San Francisco City Hall was illuminated in orange on May 9, 2026, in recognition of Bladder Cancer Awareness Month and the city’s inaugural in-person Walk to End Bladder Cancer, a milestone reflecting the strength and leadership of UCSF’s nationally recognized bladder cancer program. Mayor Daniel
Overcoming Drug Resistance, Precision Therapies Among Cancer Conference Talks
Leading cancer researchers from UC San Francisco will present talks on environmental and genetic determinants in cancer development, precision cancer treatment with radiotheranostics, overcoming drug resistance, and other cancer research topics at this year’s annual meeting of the American
“Love Island-Style” Power Couple Might Help Unlock HER2 Cancer
In the world of cancer, researchers devote a lot of time to studying the protein receptors HER2 and HER3, which, when paired together can turn into a toxic power couple. Normally, HER2 and HER3 — which are found on all kinds of human cells — help regulate cell growth and survival, according to
Michael Bishop, Nobel-Winning Cancer Researcher, Has Died at 90
UC San Francisco Chancellor emeritus J. Michael Bishop, MD, a pioneering microbiologist who shared the 1989 Nobel Prize in Physiology or Medicine for discovering that every cell in the body harbors genes that can cause cancer, has died at the age of 90. “Mike Bishop was a titan of science and a
Scientists Create Cancer-Fighting Immune Cells Right in the Body
For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized facility where they’re genetically reprogrammed to fight cancer, then ship them back for infusion
Molecular Garbage on Tumors Makes Easy Target for Antibody Drugs
For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only appeared on the inside of cells, where it sent signals that fueled tumor growth and stayed hidden from the immune system. But now researchers at UC San Francisco have